Multi-Banner Cannabis Retailer's Q3 Revenue Slumps Over 42% YoY But CEO Remains Optimistic

Zinger Key Points
  • Shiny Health & Wellness Corp. reported a year-over-year drop in quarterly sales to CA$4.3 million ($3.2 million) from CA$7.46 million in Q3.
  • Net loss for the period was roughly CA$6 million, up from CA$1.75 million in the corresponding quarter of last year.

Shiny Health & Wellness Corp. SNYB announced its third quarter fiscal year 2024 financial results for the three months ended Oct. 31, 2023, revealing a year-over-year drop in quarterly sales to CA$4.3 million ($3.2 million) from CA$7.46 million.

The Toronto-based company said the drop in revenue was consistent with trends observed in the Ontario cannabis retail market over the period.

Revenues were also reduced as a result of deliberate moves by management to close certain non-performing adult-use cannabis dispensaries and sell some of the larger footprint stores, Shiny Health said in a press release.

The company recently signed an asset purchase agreement with Karan S. Holla for his Stash & Co. Ontario chain of 10 adult-use cannabis retail stores.

“The Company is systematically building a strong brand presence in Ontario," CEO Meris Kott said. "We are excited to complete the Stash & Co. acquisition and add 10 more stores and another well-recognized brand."

Q3 2024 Financial Highlights

  • Gross profit totaled CA$1.46 million, down from CA$2.81 million in the third quarter of last year.
  • Total expenses amounted to CA$2.21 million, down from CA$3.7 million in the prior year's period.
  • Net loss for the period was roughly CA$6 million, up from CA$1.75 million in the corresponding quarter of last year.
  • As of Oct. 31. The company had CA$11.2 million in total assets and CA$16.3 million in total liabilities, down from CA$22.6 million and CA$19.6 million, respectively, as of Jan. 31. 2023.
  • Cash at the end of the period was CA$239,817, compared to CA$1.13 million on Oct. 31, 2022.

What's Next

CEO Kott said he will push to bring Shiny Health to the "next stage of development."

"We are focused on becoming a dark horse in the consolidation of the Canadian cannabis sector," she added.

Missed the first wave of cannabis investments? Don't make that mistake again.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth.
Join Benzinga PotProfits. Our in-house canna stock expert, Michael Berger, is on a mission to uncover the most promising cannabis stocks poised for growth, even in a dull market. He leaves no bud unturned to bring you the juiciest potential double-digit opportunities!
 Just this year, the PotProfits portfolio has seen smoking-hot gains like:

  •  47.10% with $GTBIF
  •  40.23% with $TCNNF
  •  21.50% with $VFF

 But here's the kicker: Michael is about to release his next potential winners, and he's chomping at the bit to share these ticker symbols with you ASAP.

Don't miss out on the green rush!

Related News

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.